Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Lidiando juntos: Intervenciones basadas en la pareja para el cáncer (CCST2)

13 de noviembre de 2026 actualizado por: Duke University

Capacitación en habilidades de comunicación de pareja para cáncer avanzado

The objective of the proposed study is to evaluate the Couple Communication Skills Training (CCST) intervention in 250 patients with advanced cancer and their spouses/intimate partners. Couples will be randomized 1:1 to receive either the CCST or to an attention control condition (Healthy Living Information; HLI). We will evaluate CCST effects on a range of patient and partner relationship and psychological outcomes.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

For patients and their intimate partners, advanced cancer poses significant challenges that can negatively impact both individuals and the couple's collective well-being. Couples' ability to communicate openly and effectively with each other about cancer-related concerns can improve their psychological adjustment and quality of their relationship. Open and effective communication may also lead to better symptom management and goal-concordant care. However, many couples report difficulties communicating about cancer, even in the context of overall satisfying relationships. This can have a number of deleterious consequences, including deficits in emotional support, decreases in intimacy and relationship quality, and increased psychological distress. Thus, interventions designed to facilitate effective communication between cancer patients and their partners are likely to have beneficial effects on both individual and relationship functioning.

Prior research, including studies conducted by our team, has found that couple-based interventions that target communication lead to positive outcomes for cancer patients and their partners. However, most prior studies have been limited by reliance on an in-person treatment delivery format which keeps many couples from participating. In addition, prior studies have not targeted interventions to couples who are most likely to benefit. There is increasing evidence that psychosocial interventions for cancer, including couple-based interventions, should be targeted to those at risk of poor outcomes. Our prior research indicates that couples who report communication difficulties (e.g., high levels of holding back from discussing cancer-related concerns) have increased psychological distress and poorer relationship functioning and are most likely to benefit from a couple communication intervention specifically designed to addressed their communication problems.

The specific aims of this study are (1)To determine whether CCST significantly improves patients' and partners' individual psychological adjustment (i.e., psychological distress, life completion) and patient health and health care outcomes (physical well-being, symptom distress, advance care planning discussions and completion of advance directives, hospitalizations, and emergency department visits) compared to an education condition. (2) To determine whether, for couples receiving the CCST intervention, improvements in psychological adjustment, relationship functioning, and patient health are mediated by improvements in their communication, including objective measures of communication quality and communal coping (e.g., "we-talk") derived from couple conversations and self-reported protective buffering. (3) To examine differences in response to the CCST intervention for patients versus partners, for male versus female participants, and for patients with different cancer diagnoses (breast, lung, GI, GU). (4) To conduct an implementation-related process evaluation of the intervention.

Tipo de estudio

Intervencionista

Inscripción (Actual)

440

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • North Carolina
      • Durham, North Carolina, Estados Unidos, 27705
        • Duke University Medical Center

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  1. Married or in a committed intimate relationship
  2. Diagnosis of one the following advanced cancers: Stage IIIB or IV non-small cell lung cancer or extensive stage small cell lung cancer, Stage III pancreatic cancer or Stage IV GI cancer, Stage IV GU cancer, Stage IV breast cancer and GYN cancer Stage III-IV ovarian, IV uterine, IV cervical.
  3. Both members of the couple must speak and read English.
  4. Patient and/or partner scores >=1.0 on the Holding Back screen.

Exclusion Criteria:

  1. Patient lacks capacity for interview (documented diagnosis of active psychosis or dementia) or is unable to provide informed consent as assessed by research staff.
  2. Patient has a life expectancy < 6 months as estimated by his/her treating oncologist.
  3. Patient or partner is physically impaired in such a way that precludes the use of a computer or videoconferencing.
  4. Patient or partner is too sick to participate, as judged by the oncologist or research staff.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Otro: Couple Communication and Support

CCST includes components to assist couples in communicating effectively, decreasing avoidance of important cancer-related issues, and providing each other with support. It includes training in skills for sharing one's thoughts and feelings and listening to one's partner and responding in a supportive manner, and joint problem solving. Participants will be asked to participate inactivities at home between sessions to strengthen skills acquisition.

Participants attend six 60-minute sessions consisting of education and skills training to enhance cancer-related communication.

Otros nombres:
  • CCST
Otro: Healthy Lifestyle Informaion

Healthy Lifestyle Information provides couples with health information relevant to cancer in a supportive environment. Sessions focus on the following topics: fatigue, sleep disturbance, nutrition, physical activity, survivorship care plans, and palliative care. Patients and partners are invited to discuss their experiences around the session topics with the therapist and ask questions about the information presented.

Participants attend attend six 60-minute sessions consisting of information and support across a range of cancer-related topics.

Otros nombres:
  • HLI

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Changes in patient relationship functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient relationship satisfaction measured by the Couples Satisfaction Inventory (higher scores indicate higher satisfaction)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner relationship functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner relationship satisfaction measured by the Couples Satisfaction Inventory (higher scores indicate higher satisfaction)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient relationship functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient intimacy as measured by the Miller Social Intimacy Scale (higher scores indicate higher intimacy)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner relationship functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner intimacy as measured by the Miller Social Intimacy Scale (higher scores indicate higher intimacy)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Changes in patient psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient psychological distress measured by the Hospital Anxiety and Depression Scale (higher scores indicate higher distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner psychological distress measured by the Hospital Anxiety and Depression Scale (higher scores indicate higher distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient mood as measured by the Positive and Negative Mood Scale (higher scores on the positive and negative mood subscales indicate higher negative and positive mood, respectively)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner mood as measured by the Positive and Negative Mood Scale (higher scores on the positive and negative mood subscales indicate higher negative and positive mood, respectively)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient life completion measured by the Life Completion scale of the QUAL-E (higher scores indicate higher completion)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner life completion measured by the Life Completion scale of the QUAL-E Family (higher scores indicate higher completion)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient physical well being as measured by the Physical Well Being subscale of the Functional Assessment of Cancer Therapy scale (higher scores indicate higher physical well being)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient and partner psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in symptom distress as measured by the Condensed Memorial Symptom Assessment Scale (higher scores indicate higher symptom distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient advance care planning discussions (presence or absence, via patient self-report)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient completion of advanced directives (presence or absence, via patient self-report)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient hospitalizations (number of hospitalizations per patient self-report, validated by medical record review)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Periodo de tiempo: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient emergency department visits (number of emergency department visits per patient self-report, validated by medical record review)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Laura Porter, PhD, Duke

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

20 de octubre de 2020

Finalización primaria (Actual)

31 de diciembre de 2025

Finalización del estudio (Actual)

31 de diciembre de 2025

Fechas de registro del estudio

Enviado por primera vez

9 de octubre de 2020

Primero enviado que cumplió con los criterios de control de calidad

15 de octubre de 2020

Publicado por primera vez (Actual)

19 de octubre de 2020

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • Pro00103232

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .